Theratechnologies Net Worth

Theratechnologies Net Worth Breakdown

  THTX
The net worth of Theratechnologies is the difference between its total assets and liabilities. Theratechnologies' net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Theratechnologies' assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Theratechnologies' net worth can be used as a measure of its financial health and stability which can help investors to decide if Theratechnologies is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Theratechnologies stock.

Theratechnologies Net Worth Analysis

Theratechnologies' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Theratechnologies' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Theratechnologies' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Theratechnologies' net worth analysis. One common approach is to calculate Theratechnologies' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Theratechnologies' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Theratechnologies' net worth. This approach calculates the present value of Theratechnologies' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Theratechnologies' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Theratechnologies' net worth. This involves comparing Theratechnologies' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Theratechnologies' net worth relative to its peers.
To determine if Theratechnologies is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Theratechnologies' net worth research are outlined below:
Theratechnologies generated a negative expected return over the last 90 days
Theratechnologies may become a speculative penny stock
Theratechnologies has high historical volatility and very poor performance
Theratechnologies has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 81.76 M. Net Loss for the year was (23.96 M) with profit before overhead, payroll, taxes, and interest of 56.22 M.
Theratechnologies currently holds about 36.46 M in cash with (5.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.38.
Theratechnologies uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Theratechnologies. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Theratechnologies' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
27th of February 2024
Upcoming Quarterly Report
View
10th of April 2024
Next Financial Report
View
30th of November 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
31st of August 2023
Last Quarter Report
View
30th of November 2022
Last Financial Announcement
View

Follow Theratechnologies' market capitalization trends

The company currently falls under 'Micro-Cap' category with a current market capitalization of 55.18 M.

Project Theratechnologies' profitablity

The company has Profit Margin (PM) of (0.04) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.27 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.27.
When accessing Theratechnologies' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Theratechnologies' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Theratechnologies' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Theratechnologies' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Theratechnologies. Check Theratechnologies' Beneish M Score to see the likelihood of Theratechnologies' management manipulating its earnings.
Theratechnologies time-series forecasting models is one of many Theratechnologies' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Theratechnologies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Theratechnologies Earnings per Share Projection vs Actual

Theratechnologies Corporate Management

LLB BAVP AffairsProfile
H MScVice ResourcesProfile
LLB LLMGeneral SecretaryProfile
Elif McDonaldDirector RelationsProfile
Christian MarsolaisSenior OfficerProfile

Additional Tools for Theratechnologies Stock Analysis

When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.